Oral Novo Nordisk diabetes drug poses no more heart risk than placebo: study

64

An experimental oral form of a Novo Nordisk drug for type 2 diabetes posed no greater risk of serious heart problems or death than a placebo in patients at high risk for such complications, according to data from a large study presented on Tuesday.

http://feeds.reuters.com/~r/reuters/healthNews/~3/7mzMz8IzhPs/oral-novo-nordisk-diabetes-drug-poses-no-more-heart-risk-than-placebo-study-idUSKCN1TC2FN